Skip Navigation


JAC Advance Access originally published online on April 28, 2005
Journal of Antimicrobial Chemotherapy 2005 55(6):897-904; doi:10.1093/jac/dki094
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/6/897    most recent
dki094v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Lemaire, S.
Right arrow Articles by Tulkens, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lemaire, S.
Right arrow Articles by Tulkens, P. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Activity of three ß-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus

Sandrine Lemaire, Françoise Van Bambeke, Marie-Paule Mingeot-Leclercq and Paul M. Tulkens*

Unité de Pharmacologie cellulaire et moléculaire, Université catholique de Louvain, Brussels, Belgium

* Corresponding author. Tel: +32-2-762-21-36 or +32-2-764-73-70; Fax: +32-2-7647373; Email: tulkens{at}facm.ucl.ac.be

Objectives: Assessment of the activity of three ß-lactams [ertapenem (a carbapenem with a prolonged half-life), meropenem and ampicillin] against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.

Methods: Quantitative measurements of cfu changes in broth and in THP-1 macrophages (post-phagocytosis) over time (5 and 24 h) at concentrations spanning from sub-MICs to Cmax (maximal concentration typically observed in patients' serum upon administration of conventional doses); morphological studies using an electron microscope; evaluation of drug stability (HPLC), protein binding (equilibrium dialysis) and measurement of drug cellular accumulation (microbiological assay).

Results: Ertapenem was unable to control L. monocytogenes growth in THP-1 macrophages at all concentrations and times tested, even under conditions where ampicillin and meropenem were bactericidal. This behaviour could not be ascribed to drug instability, protein binding or lack of cell accumulation in comparison with ampicillin or meropenem. Ertapenem, ampicillin and meropenem were equally effective at reducing the post-phagocytosis inoculum of S. aureus (~1 log cfu), and caused conspicuous changes in the morphology of intracellular bacteria consistent with their lysis. These effects were obtained, however, only at large multiples (100-fold or more) of the MIC maintained over 24 h. Because of the high intrinsic antimicrobial potency of the ß-lactams studied, these concentrations were below the Cmax.

Conclusions: Ertapenem will probably be ineffective against intraphagocytic forms of L. monocytogenes for reasons that remain to be discovered. Conversely, ertapenem could be an alternative to ampicillin and meropenem against intraphagocytic S. aureus since its longer half-life may allow high concentrations to be maintained for more prolonged times.

Keywords: L. monocytogenes , S. aureus , THP-1 macrophages , ertapenem , ampicillin , meropenem


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
S. Lemaire, A. Olivier, F. Van Bambeke, P. M. Tulkens, P. C. Appelbaum, and Y. Glupczynski
Restoration of Susceptibility of Intracellular Methicillin-Resistant Staphylococcus aureus to {beta}-Lactams: Comparison of Strains, Cells, and Antibiotics
Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2797 - 2805.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Grayo, O. Join-Lambert, M. C. Desroches, and A. Le Monnier
Comparison of the In Vitro Efficacies of Moxifloxacin and Amoxicillin against Listeria monocytogenes
Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1697 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Lemaire, F. Van Bambeke, M.-P. Mingeot-Leclercq, and P. M. Tulkens
Modulation of the Cellular Accumulation and Intracellular Activity of Daptomycin towards Phagocytized Staphylococcus aureus by the P-Glycoprotein (MDR1) Efflux Transporter in Human THP-1 Macrophages and Madin-Darby Canine Kidney Cells
Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2748 - 2757.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Lemaire, F. Van Bambeke, M.-P. Mingeot-Leclercq, Y. Glupczynski, and P. M. Tulkens
Role of Acidic pH in the Susceptibility of Intraphagocytic Methicillin-Resistant Staphylococcus aureus Strains to Meropenem and Cloxacillin
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1627 - 1632.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. Baudoux, N. Bles, S. Lemaire, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke
Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections
J. Antimicrob. Chemother., February 1, 2007; 59(2): 246 - 253.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
M. Barcia-Macay, S. Lemaire, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke
Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
J. Antimicrob. Chemother., December 1, 2006; 58(6): 1177 - 1184.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Barcia-Macay, C. Seral, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke
Pharmacodynamic Evaluation of the Intracellular Activities of Antibiotics against Staphylococcus aureus in a Model of THP-1 Macrophages
Antimicrob. Agents Chemother., March 1, 2006; 50(3): 841 - 851.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.